Literature DB >> 19682461

Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction.

Yao Sun1.   

Abstract

The circulating renin-angiotensin system (RAS) is a classic endocrine system that regulates cardiovascular homeostasis during physiologic and pathologic states. Accumulated evidence has shown the presence of components of RAS in various tissues, which are upregulated in certain pathological conditions. Locally produced angiotensin (Ang)II may play an important role in tissue repair/remodeling in autocrine and/or paracrine manners. Following acute myocardial infarction (MI), cardiac repair occurs in the infarcted myocardium and structural remodeling is developed in noninfarcted myocardium, which are accompanied by activated cardiac RAS. In this review, the current understanding of independent activation of cardiac RAS and its regulation in the pathogenesis of myocardial repair/remodeling after MI is discussed. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2009        PMID： 19682461      PMCID： PMC2823992          DOI： 10.1016/j.yjmcc.2009.08.002

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


  56 in total

1.  Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction.

Authors:  G Gabbiani; G B Ryan; G Majne
Journal:  Experientia       Date:  1971-05-15

2.  Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue.

Authors:  Li Lu; John Q Zhang; Felix J Ramires; Yao Sun
Journal:  Biochem Biophys Res Commun       Date:  2004-07-30       Impact factor: 3.575

3.  Activation of nuclear factor-kappaB and its proinflammatory mediator cascade in the infarcted rat heart.

Authors:  Li Lu; Sue S Chen; John Q Zhang; Felix J Ramires; Yao Sun
Journal:  Biochem Biophys Res Commun       Date:  2004-09-03       Impact factor: 3.575

4.  Neural regulation of the proinflammatory cytokine response to acute myocardial infarction.

Authors:  Joseph Francis; Zhi-Hua Zhang; Robert M Weiss; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08       Impact factor: 4.733

5.  Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction.

Authors:  B I Jugdutt; B L Schwarz-Michorowski; M I Khan
Journal:  J Am Coll Cardiol       Date:  1992-03-01       Impact factor: 24.094

6.  Angiotensin AT1 receptor upregulates expression of basic fibroblast growth factor, basic fibroblast growth factor receptor and coreceptor in human coronary smooth muscle cells.

Authors:  Adriane Skaletz-Rorowski; Kai Pinkernell; Jürgen R Sindermann; Christoph Schriever; Joachim G Müller; Heike Eschert; Günter Breithardt
Journal:  Basic Res Cardiol       Date:  2004-02-05       Impact factor: 17.165

Review 7.  Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II.

Authors:  Rajiv Agarwal; Ruth C Campbell; David G Warnock
Journal:  Semin Nephrol       Date:  2004-03       Impact factor: 5.299

8.  Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium.

Authors:  Haruhiro Toko; Yunzeng Zou; Tohru Minamino; Masanori Masaya; Mutsuo Harada; Toshio Nagai; Takeshi Sugaya; Fumio Terasaki; Yasushi Kitaura; Issei Komuro
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-02-12       Impact factor: 8.311

9.  Neurohumoral responses to chronic myocardial infarction in rats.

Authors:  G P Hodsman; M Kohzuki; L G Howes; E Sumithran; K Tsunoda; C I Johnston
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

10.  Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis.

Authors:  Miguel Luis Graciano; Rita de Cassia Cavaglieri; Humberto Dellê; Wagner Vasquez Dominguez; Dulce Elena Casarini; Denise Maria Avancini Costa Malheiros; Irene L Noronha
Journal:  J Am Soc Nephrol       Date:  2004-07       Impact factor: 10.121
View more
  24 in total

1.  Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells.

Authors:  Young H Lee; Ognoon Mungunsukh; Rebecca L Tutino; Ana P Marquez; Regina M Day
Journal:  J Cell Sci       Date:  2010-04-20       Impact factor: 5.285

2.  Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure.

Authors:  Ryo Watanabe; Jun-Ichi Suzuki; Kouji Wakayama; Hidetoshi Kumagai; Yuichi Ikeda; Hiroshi Akazawa; Issei Komuro; Mitsuaki Isobe
Journal:  Hypertens Res       Date:  2015-12-10       Impact factor: 3.872

3.  [Irbesartan ameliorates cardiac inflammation in type 2 diabetic db/db mice].

Authors:  Xian-Lang Ye; Wei-Chang Huang; Yan-Tao Zheng; Ying Liang; Wang-Qiu Gong; Chong-Miao Yang; Bin Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

4.  Ischemia/reperfusion injury: The role of immune cells.

Authors:  Mozow Y Zuidema; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-10-26

5.  Molecular hybrid positron emission tomography/computed tomography imaging of cardiac angiotensin II type 1 receptors.

Authors:  Kenji Fukushima; Paco E Bravo; Takahiro Higuchi; Karl H Schuleri; Xiaoping Lin; M Roselle Abraham; Jinsong Xia; William B Mathews; Robert F Dannals; Albert C Lardo; Zsolt Szabo; Frank M Bengel
Journal:  J Am Coll Cardiol       Date:  2012-11-14       Impact factor: 24.094

6.  Myocardial infarct size and area at risk assessment in mice.

Authors:  Bjorn Redfors; Yangzhen Shao; Elmir Omerovic
Journal:  Exp Clin Cardiol       Date:  2012

7.  Understanding the role of the extracellular matrix in cardiovascular development and disease: where do we go from here?

Authors:  Merry L Lindsey; Thomas K Borg
Journal:  J Mol Cell Cardiol       Date:  2009-09-23       Impact factor: 5.000

Review 8.  Myocardial regeneration of the failing heart.

Authors:  Alexander T Akhmedov; José Marín-García
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

9.  Olmesartan prevents cardiac rupture in mice with myocardial infarction by modulating growth differentiation factor 15 and p53.

Authors:  Baihe Chen; Di Lu; Yujuan Fu; Jingwen Zhang; Xiaobo Huang; Shiping Cao; Dingli Xu; Jianping Bin; Masafumi Kitakaze; Qiaobing Huang; Yulin Liao
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 10.  Nicotine and the renin-angiotensin system.

Authors:  Joshua M Oakes; Robert M Fuchs; Jason D Gardner; Eric Lazartigues; Xinping Yue
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-08-08       Impact factor: 3.619
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.